Possible shifts in paradigms for lipid-lowering therapies in acute coronary syndrome patients: PCSK9 inhibitors from Day 1
30 August 2024 (08:00 - 17:30)
Organised by: 
About the speaker
McMaster University, Hamilton (Canada)
3 More presentations in this session
Access the full session
The Event
ESC Congress 2024
30 August - 2 September 2024
